Reading Time: 4 minutesEach year, the MND Association dedicates the month of June to raising MND awareness. This year, we focus on the eyes – in most people
Tag: clinical trials
Reading Time: 2 minutesOn Friday 5 May in America, the FDA, the organisation that approves drugs, announced that they’d granted a licence for the drug known as a
Reading Time: 2 minutesA few months ago we wrote an article about the ALS Clinical Trials Workshop which took place in Virginia, USA. Since then the Guidelines Working
Reading Time: 5 minutesClinical trials determine if potential treatments are safe and aim to prove beyond reasonable doubt whether a drug is beneficial. They are therefore the gold
Reading Time: 3 minutesBar a few bacteria usually found hitching a ride on our dental plaque and digestive system, every living cell in the human body needs oxygen.
Reading Time: 3 minutesThe MND Association’s Director of Research, Brian Dickie explains more about ‘GM6’, also known as ‘GM604’, a drug in development by an American pharmaceutical company
Reading Time: 4 minutesOn 22 September 2014 Neuralstem announced the results from their long-term follow up of three participants who were involved in their initial phase I safety
Reading Time: 4 minutesA number of articles were published in various news sources on 11 July 2014, highlighting how scientists in Sheffield are working towards testing a promising
Reading Time: 4 minutesLast month the UK Government’s Department of Health announced an Early Access to Medicines Scheme. But, what is this new scheme? and what does it
Reading Time: 2 minutesA packed room at the 24th International Symposium on ALS/MND was given a fascinating whistle stop tour covering stem cells, robots and cellular garbage clearing,